rs1801282 — PPARG Pro12Ala

Insulin sensitivity - affects how well your cells respond to insulin

See your personal result for PPARG

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

PPARG — The Insulin Sensitivity Gene

PPARG11 Full name: Peroxisome Proliferator-Activated Receptor Gamma is a nuclear receptor22 Nuclear receptors are proteins that bind to DNA and directly regulate gene expression in response to hormones and metabolites that regulates fatty acid storage and glucose metabolism. It's the target of thiazolidinedione33 Thiazolidinediones (e.g. pioglitazone) are diabetes drugs that work by activating PPARG to improve insulin sensitivity drugs used to treat type 2 diabetes.

The Mechanism

The Pro12Ala variant (rs1801282) is a missense mutation in exon B of PPARG, where a cytosine-to-guanine change substitutes proline with alanine at position 12 (p.Pro12Ala). This occurs in the ligand-independent activation domain of the PPARγ2 isoform. The Ala (G) allele reduces PPARG transcriptional activity slightly, which paradoxically improves insulin sensitivity — likely because excessive PPARG activity promotes fat storage.

The Evidence

The original discovery by Deeb et al.44 original discovery by Deeb et al.
Deeb et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 1998 demonstrated that the Ala allele reduces receptor activity and is associated with lower BMI and better insulin sensitivity in Finnish populations.

Altshuler et al.55 Altshuler et al.
Altshuler et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet, 2000 confirmed in over 3,000 individuals that the common Pro allele (C) carries a modest 1.25-fold increase in diabetes risk compared to the Ala allele (G).

A HuGE meta-analysis of 60 studies66 HuGE meta-analysis of 60 studies
Gouda et al. The association between the PPARG2 Pro12Ala gene variant and T2DM. Am J Epidemiol, 2010 involving 32,849 cases and 47,456 controls confirmed the protective effect of Ala12 (OR 0.86).

Practical Implications

The Pro (C) allele is the common variant (~75% of Europeans are CC). Having one or two copies of the Ala (G) allele is protective — it improves how your cells respond to insulin. The G allele is rare in African populations (~1%) but more common in European and South Asian populations (~11-12%).

Interactions

PPARG interacts with TCF7L2 (rs7903146) in determining overall diabetes risk. If you carry the protective Ala allele here but the risk T allele at TCF7L2, the effects may partially offset each other. PPARG is also the target of thiazolidinedione drugs — carriers of Ala12 may respond differently to these medications.

Nutrient Interactions

dietary fat altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

CC Standard Insulin Response Normal

Common Pro/Pro variant

You have the most common PPARG genotype (Pro/Pro), shared by about 75% of people of European descent. Your insulin sensitivity is typical for the population. The Pro allele has slightly higher PPARG activity, which is associated with a modest 1.25-fold increase in type 2 diabetes risk compared to Ala carriers — but this is a small effect that is easily managed through lifestyle.

GG Best Insulin Sensitivity Beneficial

Two Ala alleles - best insulin sensitivity

You have two copies of the protective Ala allele (Ala/Ala), a genotype found in only about 2% of Europeans. This is associated with the best insulin sensitivity of all PPARG genotypes and the lowest PPARG-related diabetes risk.

CG Improved Insulin Sensitivity Beneficial

One Ala allele - improved insulin sensitivity

You carry one copy of the protective Ala allele (Pro/Ala), shared by about 23% of Europeans. This variant is associated with better insulin sensitivity compared to the common Pro/Pro genotype, conferring about a 14% reduced risk of type 2 diabetes.